GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kainos Medicine Inc (XKRX:284620) » Definitions » Sale Of Investment

Kainos Medicine (XKRX:284620) Sale Of Investment : ₩3,303.5 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Kainos Medicine Sale Of Investment?

Kainos Medicine's sale of investment for the three months ended in Dec. 2024 was ₩0.0 Mil. It means Kainos Medicine gained ₩0.0 Mil from selling investments. Kainos Medicine's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was ₩3,303.5 Mil.

Compared with last quarter (₩0.0 Mil in Sep. 2024 ), Kainos Medicine gained the same money from selling investments in Dec. 2024 (₩0.0 Mil).


Kainos Medicine Sale Of Investment Historical Data

The historical data trend for Kainos Medicine's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kainos Medicine Sale Of Investment Chart

Kainos Medicine Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial 9,135.53 1,860.40 46,011.54 5,000.00 3,303.50

Kainos Medicine Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3,177.21 126.29 - -

Kainos Medicine Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,303.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kainos Medicine Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Kainos Medicine's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Kainos Medicine Business Description

Traded in Other Exchanges
N/A
Address
16, Daewangpangyo-ro 712 beon-gil, 4th Floor, Institut Pasteur Korea, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13488
Kainos Medicine Inc conducts research and develops medicines used to treat brain diseases, cancers, and infectious diseases.

Kainos Medicine Headlines

No Headlines